JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB31925

Mouse monoclonal [4D2D9G8] Anti-Human IgG Fc

Be the first to review this product! Submit a review

|

(0 Publication)

Suitable for ELISA, WB.

View Alternative Names

Immunoglobulin heavy constant gamma 1, Ig gamma-1 chain C region, Ig gamma-1 chain C region EU, Ig gamma-1 chain C region KOL, Ig gamma-1 chain C region NIE, IGHG1

1 Images
Western blot - Mouse monoclonal [4D2D9G8] Anti-Human IgG Fc (AB31925)
  • WB

Unknown

Western blot - Mouse monoclonal [4D2D9G8] Anti-Human IgG Fc (AB31925)

Lane 1:

Human serum protein at 100 µg

Lane 2:

Human plasma protein at 100 µg

Secondary

Lanes 1 - 2:

HRP-conjugated Goat polyclonal to mouse IgG1

Lanes 1 - 2:

Western blot - Mouse monoclonal [4D2D9G8] Anti-Human IgG Fc (ab31925) at 1/500 dilution

false

Key facts

Host species

Mouse

Target species

Human

Target isotype

IgG

Target specificity

Fc region

Minimal cross-reactivity
Pre-adsorbed

No

Applications

ELISA, WB

applications

Clonality

Monoclonal

Clone number

4D2D9G8

Isotype

IgG1

Immunogen

Synthetic Peptide within Human IGHG1. The exact immunogen used to generate this antibody is proprietary information.

P01857

Specificity

ab31925 is specific for the whole human IgG molecule, has no across action with human IgM molecule as determined by an ELISA. Reactivity is observed with all human IgG subclasses but not with the Fab fragment of human IgG.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "ELISA": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"1/10000", "notes":"<p></p>" }, "WB": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"1/200 - 1/1000", "notes":"<p></p>" } } }

Product details

This product was changed from ascites to supernatant. Lot no's high than GR169873-21 are from Tissue Culture Supernatant

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein G
Purification notes
Purified from tissue culture supernatant.
Storage buffer
Preservative: 0.05% Sodium azide Constituents: PBS
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Product protocols

Target data

Constant region of immunoglobulin heavy chains. Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which results in the elimination of bound antigens (PubMed : 20176268, PubMed : 22158414). The antigen binding site is formed by the variable domain of one heavy chain, together with that of its associated light chain. Thus, each immunoglobulin has two antigen binding sites with remarkable affinity for a particular antigen. The variable domains are assembled by a process called V-(D)-J rearrangement and can then be subjected to somatic hypermutations which, after exposure to antigen and selection, allow affinity maturation for a particular antigen (PubMed : 17576170, PubMed : 20176268). Mediates IgG effector functions on monocytes triggering ADCC of virus-infected cells.
See full target information IGHG1

Additional targets

IGHG4,IGHG3,IGHG2

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com